Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/21732
Title: | Tolerogenic Dendritic Cells Generated by In Vitro Treatment With SAHA Are Not Stable In Vivo | Authors: | THEWISSEN, Kristof BROUX, Bieke HENDRIKS, Jerome Vanhees, Mandy STINISSEN, Piet SLAETS, Leen HELLINGS, Niels |
Issue Date: | 2016 | Publisher: | COGNIZANT COMMUNICATION CORP | Source: | Cell transplantation, 25 (6), p. 1207-1218 | Abstract: | The aim of this study is to examine whether the histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), can generate dendritic cells (DCs) with a stable tolerogenic phenotype to counteract autoimmune responses in an animal model of multiple sclerosis. We investigated if the tolerogenic potency of DCs could be increased by continuous treatment during in vitro differentiation toward DCs compared to standard 24-h in vitro treatment of already terminally differentiated DCs. We show that in vitro treatment with SAHA reduces the generation of new CD11c(+) DCs out of mouse bone marrow. SAHA-generated DCs show reduced antigen-presenting function as evidenced by a reduction in myelin endocytosis, a decreased MHC II expression, and a failure to upregulate costimulatory molecules upon LPS challenge. In addition, SAHA-generated DCs display a reduction in proinflammatory cytokines and molecules involved in apoptosis induction, inflammatory migration, and TLR signaling, and they are less immunostimulatory compared to untreated DCs. We demonstrated that the underlying mechanism involves a diminished STAT1 phosphorylation and was independent of STAT6 activation. Although in vitro results were promising, SAHA-generated DCs were not able to alleviate the development of experimental autoimmune encephalomyelitis in mice. In vitro washout experiments demonstrated that the tolerogenic phenotype of SAHA-treated DCs is reversible. Taken together, while SAHA potently boosts tolerogenic properties in DCs during the differentiation process in vitro, SAHA-generated DCs were unable to reduce autoimmunity in vivo. Our results imply that caution needs to be taken when developing DC-based therapies to induce tolerance in the context of autoimmune disease. | Notes: | [Thewissen, Kristof; Broux, Bieke; Hendriks, Jerome J. A.; Stinissen, Piet; Slaets, Helena; Hellings, Niels] Hasselt Univ, Biomed Res Inst, Diepenbeek, Belgium. [Thewissen, Kristof; Broux, Bieke; Hendriks, Jerome J. A.; Stinissen, Piet; Slaets, Helena; Hellings, Niels] Transnat Univ Limburg, Sch Life Sci, Diepenbeek, Belgium. [Vanhees, Mandy] Univ Ghent, Dept Clin Chem Microbiol & Immunol, B-9000 Ghent, Belgium. | Keywords: | Dendritic cells (DCs); Multiple sclerosis; Histone deacetylase inhibitor; Anti-inflammatory; Tolerance;Dendritic cells (DCs); multiple sclerosis; histone deacetylase inhibitor; anti-inflammatory; tolerance | Document URI: | http://hdl.handle.net/1942/21732 | ISSN: | 0963-6897 | e-ISSN: | 1555-3892 | DOI: | 10.3727/096368915X690305 | ISI #: | 000377847700015 | Rights: | Copyright © 2016 Cognizant, LLC. | Category: | A1 | Type: | Journal Contribution | Validations: | ecoom 2017 |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
s15.pdf Restricted Access | Published version | 813.42 kB | Adobe PDF | View/Open Request a copy |
SCOPUSTM
Citations
5
checked on Sep 3, 2020
WEB OF SCIENCETM
Citations
4
checked on Apr 22, 2024
Page view(s)
68
checked on Jul 15, 2022
Download(s)
46
checked on Jul 15, 2022
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.